A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 111 participants.
Also called NCT03311724
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 111 participants
- Sponsor
- Registry
-
NCT03311724
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03311724. Randomized; double masking; primary purpose treatment. Start 2017-10-19 (actual); primary completion 2018-04-24 (actual). Results posted on 2021-05-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Tirzepatide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct03311724- Content hash
1d61b6d40f6fc1dc77827c6ad259b9deeb0667c721793d3cb7517fb7c1b77b2b